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ABSTRACT
A major DNA oxidation product, 2,2-diamino-4-[(2-
deoxy-b-D-erythro-pentofuranosyl)amino]-5(2H)-oxa-
zolone (oxazolone), can be generated either directly
by oxidation of dG or as a secondary oxidation
product with an intermediate of 8-oxo-7,8-dihydro-
20-deoxyguanosine (8-oxo-dG). Site-specific muta-
genesis studies indicate that oxazolone is a strongly
mispairing lesion, inducing  10-fold more muta-
tions than 8-oxo-dG. While 8-oxo-dG undergoes
facile further oxidation, oxazolone appears to be a
stable final product of guanine oxidation, and, if
formed in vivo, can potentially serve as a biomarker
of DNA damage induced by oxidative stress. In this
study, capillary liquid chromatography-electrospray
ionization tandem mass spectrometry (HPLC-ESI-
MS/MS) methods were developed to enable quanti-
tative analysis of both 8-oxo-dG and oxazolone in
DNA from biological sources. Sensitive and specific
detection of 8-oxo-dG and oxazolone in enzymatic
DNA hydrolysates was achieved by isotope dilution
with the corresponding
15N-labeled internal stan-
dards. Both nucleobase adducts were formed in a
dose-dependent manner in calf thymus DNA sub-
jectedtophotooxidationinthepresenceofriboflavin.
While the amounts of oxazolone continued to
increase with the duration of irradiation, those of
8-oxo-dG reached a maximum at 20 min, suggesting
that 8-oxo-dG is converted to secondary oxidation
products. Both lesions were found in rat liver DNA
isolated under carefully monitored conditions to
minimize artifactual oxidation. Liver DNA of diabetic
and control rats maintained on a diet high in animal
fat contained 2–6 molecules of oxazolone per
10
7 guanines, while 8-oxo-dG amounts in the same
samples were between 3 and 8 adducts per 10
6
guanines. The formation of oxazolone lesions in rat
liver DNA, their relative stability in the presence of
oxidants and their potent mispairing characteristics
suggest that oxazolone may play a role in oxidative
stress-mediated mutagenesis.
INTRODUCTION
Reactive oxygen and nitrogen species, e.g. hydrogen perox-
ide, hydroxyl radical, superoxide, peroxynitrite and singlet
oxygen, are produced in normal tissues as a result of aerobic
metabolism, immune response and inﬂammation (1,2).
The oxidative degradation of DNA has been implicated in
aging, cancer and in some degenerative diseases (3–6). For
example, smokers who exhibit low levels of hOgg1, a repair
protein responsible for the removal of oxidative DNA lesions,
are at an increased risk of lung cancer (7). Among the four
DNA bases, guanine is most susceptible to oxidation because
it has the lowest oxidation potential (8,9). Guanine oxidation
is further facilitated in the GG and GGG repeats (8,10–12).
Guanine oxidation gives rise to a variety of products, includ-
ing 8-oxo-dG, spiroiminodihydantoin, guanidinohydantoin,
2-amino-5-[2-deoxy-b-D-erythro-pentofuranosyl)amino]-4H-
imidazol-4-one (imidazolone) and its hydrolysis product,
2,2-diamino-4-[(2-deoxy-b-D-erythro-pentofuranosyl)amino]-
5(2H)-oxazolone (oxazolone) (Scheme 1) (13–19).
Oxidized DNA nucleobases measured in target tissues
can serve as biomarkers of oxidative stress and potentially,
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doi:10.1093/nar/gkl596carcinogenic risk indicators (1,20,21). 8-Oxo-dG is com-
monly used as a marker of DNA oxidation, mainly because
of its prevalence and the ease of its measurement by high-
performance liquid chromatography (HPLC) with electro-
chemical detection (22). For example, 8-oxo-dG levels have
been reported to be increased in leukocyte DNA of smokers
as compared with non-smoking controls (23). 8-Oxo-dG,
however, is also produced as an artifact from normal 20-
deoxyguanosine during sample processing, leading to overes-
timation of its amounts (24). Large discrepancies in the levels
of 8-oxo-dG determined by different laboratories are likely
due to differences in analytical procedures including DNA
extraction, hydrolysis and derivatization (20,22,24).
The use of 8-oxo-dG as a biomarker of DNA oxidation is
further complicated by its facile oxidation in the presence of
reactive oxygen and nitrogen species. Since 8-oxo-dG has a
lower redox potential than normal guanine (0.58–0.75 V
compared to 1.29 V for dG) (8,25,26), it is preferentially oxi-
dized even in the presence of a large excess of normal gua-
nines (27–29). 8-Oxo-dG has been proposed to act as a
‘trap’ for oxidative damage via the free radical or electron
hole migration to 8-oxo-dG along the DNA duplex
(8,15,17,29,30). In the event that 8-oxo-dG is speciﬁcally tar-
geted for further oxidation in vivo upon long-term exposure of
cellular DNA to oxidants, its use as a biomarker of oxidative
stress may be misleading. On the other hand, the secondary
products resulting from further oxidation of 8-oxo-dG, e.g.
oxazolone, oxaluric acid, cyanuruc acid, guanidinohydantoin,
5-guanidino-4-nitroimidazole and urea, are mispairing lesions
that may, in turn, play a role in mutagenesis of reactive oxygen
species (ROS) (31–35).
Oxazolone is generated via spontaneous hydrolysis of imi-
dazolone, which can be produced directly by oxidation of
guanine nucleobases in DNA or as a secondary oxidation
product with an intermediate of 8-oxo-dG (Scheme 1)
(10,18,19,36). Imidazolone and oxazolone lesions have been
found in DNA following exposure to Type I photo-oxidizing
agents, ionizing radiation, superoxide radicals and peroxyni-
trite (14,37–40). Kino and Saito (10) proposed that imida-
zolone and oxazolone nucleosides may be responsible for
the formation of piperidine-sensitive alkali-labile sites at the
50-guanine of 50-GG-30 sequences following one-electron
oxidation of DNA. These and other investigators have
shown that synthetic DNA oligomers containing oxazolone
are quantitatively cleaved by hot piperidine treatment at the
oxidized nucleotide, while the strand scission of the corre-
sponding 8-oxo-dG-containing oligonucleotides is inefﬁcient
(10,41). Therefore, oxazolone formation may be the underly-
ing basis for the formation of single-strand breaks following
hot piperidine treatment of ROS-treated DNA, a procedure
commonly used to assess oxidative DNA damage (42).
Primer extension studies and site-speciﬁc mutagenesis
experiments using synthetic oxazolone-containing DNA indi-
cate that oxazolone is at least an order of magnitude more
mutagenic than 8-oxo-dG, giving rise to G!T transversions
(31,43). This suggests that, if formed in vivo, oxazolone may
play a role in oxidative stress-related mutations and cancer.
Yu et al. (38) reported recently the use of HPLC-MS/MS to
quantify oxazolone lesions in calf thymus DNA treated with
varying concentrations of peroxynitrite. However, to our
knowledge, there are no previous reports of oxazolone forma-
tion in cellular DNA. It is possible that oxazolone has not
been detected among DNA lesions in vivo because of its
low yield as compared with 8-oxo-dG, its efﬁcient repair
(41,43), hydrolytic instability (36) or insufﬁciently sensitive
analytical methods for its detection.
The goal of the present investigation was to establish
whether oxazolone lesions are present in cellular DNA and
to determine their potential usefulness as a biomarker of
DNA oxidation. Previous studies demonstrated that 8-oxo-
dG and other oxidative lesions are present in normal tissues
of humans and laboratory animals with no known exposure,
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Scheme 1. Chemical structures of the oxidative DNA lesions examined in the present study.
5450 Nucleic Acids Research, 2006, Vol. 34, No. 19probably as a result of background DNA oxidation by
endogenous ROS (20,22,24). The present study uses liver
DNA isolated from streptozotocin-induced diabetic rats
exhibiting high levels of oxidative stress and lipid peroxida-
tion (44,45). Our approach is based on sensitive and speciﬁc
detection of 8-oxo-dG and oxazolone in enzymatic DNA
digests by isotope dilution HPLC-ESI-MS/MS following a
two-step off-line HPLC cleanup. Both 8-oxo-dG and oxa-
zolone were detected in liver DNA of control and diabetic
rats. The presence of oxazolone in DNA from an in vivo
source suggests a possible role for this oxidative nucleobase
lesion in mutagenesis induced by reactive oxygen and nitro-
gen species.
MATERIALS AND METHODS
Chemicals
Ammonium acetate, acetonitrile, methanol, magnesium
dichloride and the Tris base (Fisher Scientiﬁc, Hanover
Park, IL); calf thymus DNA, riboﬂavin, 8-oxo-dG, alkaline
phosphatase, manganese(IV) oxide, TEMPO and 20-
deoxyguanosine (Sigma-Aldrich, Milwaukee, WI); guanidine
thiocyanate (Promega Corporation, Madison, WI); DNase I
and Phosphodiesterases I and II (Worthington Biochemicals,
Lakewood, NJ); and
15N5-dGTP (Martek, Columbia, MD)
were from the sources indicated. Phase lock gel (heavy)
tubes (15 ml) were from Eppendorf (Hamburg, Germany).
15N5-dG:
15N5-dGTP (5 mg) was dissolved in 200 mlo f
50 mM Tris–HCl/1 mM MgCl2 buffer, pH 9, and incubated
with alkaline phosphatase (75 U) for 5 h at 37 C. The
hydrolysates were subjected to an HPLC using an Agilent
Eclipse XDB-C8 column (4.6 · 150 mm, 5 mm) and a gradi-
ent of acetonitrile (solvent B) in 150 mM ammonium acetate
(solvent A) at a ﬂow rate of 1 ml/min. The solvent composi-
tion was as follows: 0–2 min, 0% B; 15 min, 3% B; 18 min,
30% B; 25 min, 30% B. The peak corresponding to
15N5-dG
(tR¼12 min) was collected and concentrated under reduced
pressure. The identity and purity of
15N5-dG was conﬁrmed
by UV spectrophotometry, molecular weight from ESI
+ MS
and MS/MS fragmentation pattern.
Oxazolone and
15N4 –oxazolone were prepared by
riboﬂavin-mediated photooxidation of 20-dG or
15N5-dG,
respectively. 20-dG or
15N5-dG was dissolved in 800 mlo fa
saturated aqueous solution of riboﬂavin and placed in a
glass scintillation vial. The solution was continuously purged
with air, while it was irradiated for 1 h with a 75 W tungsten
lamp placed at 5 cm from the vial. The photooxidation
mixtures were separated by HPLC using the column and solv-
ent gradient described above. The peaks corresponding to
imidazolone (tR ¼ 3.2 min) and oxazolone (tR ¼ 1.9 min)
(Figure 1a) were collected and kept overnight at room tem-
perature to convert imidazolone to oxazolone. Oxazolone
was further puriﬁed by HPLC using a Thermo Hypersil-
Keystone Hypercarb column (2.1 · 100 mm, 5 mm) and a
linear gradient of acetonitrile in water (3–9% in 10 min) at
a ﬂow rate of 0.3 ml/min. The identities of puriﬁed oxazolone
(tR ¼ 6.4 min) and
15N4-oxazolone were established by
UV spectrophotometry (Figure 1b), proton NMR and ESI
+
MS (Figure 2). The amount of unlabeled oxazolone in
15N4-oxazolone stock solution was <0.65% as determined
by ESI
+ MS analysis. Concentrations of oxazolone in stock
solutions were determined by UV spectrophotometry using
the extinction coefﬁcient e233 ¼ 1.833 mM
 1 cm
 1.
15N5-8-oxo-dG was prepared by H2O2-mediated oxidation
of
15N5-dG in the presence of ascorbic acid (46). A mixture
containing 1.3 mM
15N5-dG, 10 mM ascorbic acid and
50 mM H2O2 in 0.1 M sodium phosphate, pH 6.8, was incu-
bated for 4 h at 37 C.
15N5-8-Oxo-dG was puriﬁed by
HPLC using the column and gradient described for
15N5-dG
above. The peak of
15N5-8-oxo-dG (tR ¼ 15.3 min) was col-
lected and dried under reduced pressure. The identity of the
standard was established by UV spectrophotometry and MS.
ESI MS of
15N5-8-oxo-dG: m/z 289.2 [M + H]
+, 173.2 [M +
2H – dR]
+. The amount of unlabeled 8-oxo-dG in
15N5-8-
oxo-dG stock solution was <0.1% by ESI
+ MS analysis. Con-
centrations of 8-oxo-dG in standard solutions were determined
by UV spectrophotometry (e294 ¼ 9700 M
 1 cm
 1) (47).
Photooxidation of DNA
A glass vial containing 1 mg/ml of calf thymus DNA dis-
solved in a saturated aqueous solution of riboﬂavin was
placed in ice-cold water. The solution was irradiated using
a 75 W tungsten bulb positioned at  5 cm from the vial.
The reaction mixture was continuously purged with a steady
stream of air. Aliquots of 50 ml were withdrawn at 0, 5, 10,
15, 20, 30 and 60 min. The DNA was precipitated with
cold ethanol.
Animals and treatment
The use of female Sprague–Dawley rats (Harlan Sprague
Dawley, Indianapolis, IN) was approved by the University
of Minnesota Institutional Animal Care and Use Committee.
Starting at 3 weeks of age, rats were fed a 10% beef tallow-
based diet for a total of 13 weeks as described previously
(44). Rats were injected intraperitoneally with two doses of
streptozotocin (40 mg/kg body weight at 6 weeks of age
and an additional dose of 50 mg/kg body weight at 8 weeks
of age) to induce diabetes or saline (0.9% NaCl in water, pH
7.4). Feeding was continued for another 4 weeks. At the end
of week 13, rats were fasted for 48 h and euthanized as
described previously (44). The livers were collected, frozen
and stored at  70 C.
DNA extraction from rat liver
A modiﬁcation of the method described by Hofer and Mo ¨ller
(48) was used. To minimize oxidation of DNA during the
extraction procedure, all solutions were saturated with
argon (Ar) and kept on ice. TEMPO (5 mM) was added to
all buffers as an antioxidant. Rat liver tissue (0.25–1 g) was
placed in a glass/glass homogenizer with 10 ml of homogen-
ization buffer (20 mM Tris–HCl, pH 7.5, containing 5 mM
MgCl2 and 5 mM TEMPO), and homogenized with
 10 strokes. The homogenates were transferred to a cen-
trifuge tube and centrifuged at 1000 g for 10 min at 4 C.
The nuclear pellets were suspended in 10 ml of the above
homogenization buffer containing 0.5% v/v Tween-20 and
centrifuged at 1000 g for 10 min at 4 C. This procedure
was repeated two more times. After the ﬁnal extraction, the
nuclear pellet was dissolved in 5 ml of 4 M guanidine thio-
cyanate and transferred to a 15 ml phase lock gel (heavy)
Nucleic Acids Research, 2006, Vol. 34, No. 19 5451Eppendorf tube. Each sample was mixed with 5 ml of Sevag
(a 1:24 mixture of isoamyl alcohol in chloroform) and the
tube was shaken by hand for 1 min. After centrifugation at
1500 g for 5 min at 4 C, the aqueous phase was transferred
to a clean centrifuge tube. The DNA was precipitated with
5 ml of isopropanol under Ar atmosphere overnight at
 20 C. The DNA was pelleted by centrifugation for
15 min at 9000 g at 4 C. The residual isopropanol was evapo-
rated under a ﬂow of nitrogen, and the DNA pellet was resus-
pended in 1 ml of homogenization buffer and transferred to a
clean microcentrifuge tube. RNase A (140 U) and RNase T1
(1600 U) were added, followed by incubation at 37 C for 3 h.
Proteinase K (40 U) was then added and the mixture was
incubated for additional 2 h while gently shaken every
15 min. After incubation, the mixture was transferred to a
15 ml phase lock gel tube (heavy) and 4 ml of 4 M guanidine
thiocyanate was added. Each sample was then mixed with
5 ml of Sevag and the tube were shaken by hand for 1 min.
After centrifugation at 1500 g for 5 min at 4 C, the aqueous
phase was transferred to a clean centrifuge tube. The DNA
was precipitated with isopropanol under Ar atmosphere for
30 min at  20 C. The supernatant was removed and the pel-
let was washed with 70% aqueous ethanol. After centrifuga-
tion at 9000 g at 4 C for 15 min, the DNA pellet was dried
under Ar and dissolved in water. DNA concentration was
determined by UV absorption (A260 ¼ 1 for 50 mg DNA).
Typical A260/A280 values were between 1.6 and 1.8.
Enzymatic hydrolysis of DNA
DNA samples (0.1 mg) from either in vivo or in vitro sources
were dissolved in 150 ml of 10 mM Tris–HCl buffer (pH 7)
containing 15 mM MgCl2 and 5 mM TEMPO, and spiked
with known amounts of isotopically labeled internal standards
of
15N5-8-oxo-dG and
15N4-oxazolone (12 pmol each for
in vitro samples, 1–2 pmol each for in vivo samples). DNA
hydrolysis was performed by adding a mixture of DNase I
(4 U), phosphodiesterase I (32 mU), phosphodiesterase II
(80 mU) and alkaline phosphatase (16 U), followed by incuba-
tion for 8–10 h at 37 C (22). All reagents were scaled accord-
ingly when using different DNA amounts.
To ensure the completeness of enzymatic hydrolysis, small
aliquots of the digests were analyzed by HPLC-UV using the
column (an Eclipse XDB-C8) and solvent gradient described
for
15N5-dG above. Under these conditions, normal DNA
nucleosides eluted in the following order: dC, 6 min; dG,
12.3 min; dT, 14.4 min; and dA, 18.4 min. In some cases,
20-deoxyinosine (dI) was also observed, eluting at 11.6 min.
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Figure 1. HPLC separation of the products resulting from dG photooxidation in the presence of riboflavin: (a) Separation of crude reaction mixtures by reversed
phase HPLC. An Agilent Eclipse XDB-C8 column was eluted with a gradient of acetonitrile in 150 mM ammonium acetate. (b) Further purification of oxazolone
on a carbon column. A Thermo Hypersil-Keystone Hypercarb column was eluted with a gradient of acetonitrile in water.
5452 Nucleic Acids Research, 2006, Vol. 34, No. 19dI is produced by deamination of 20-deoxyadenosine by
deaminases present in commercial alkaline phosphatase
preparations (49,50). No attempt was made to inhibit this arti-
factual deamination as it did not interfere with quantiﬁcation
of oxazolone and 8-oxo-dG (data not shown). If RNA con-
tamination was observed, RNA nucleosides eluted as follows:
cytidine, 3.7 min; uridine, 5.5 min; guanosine, 10.5 min;
adenosine, 18 min. Samples exhibiting RNA contamination
were not further analyzed. Test experiments employing imi-
dazolone standard have shown that imidazolone was quantita-
tively converted to oxazolone under the conditions of
enzymatic hydrolysis. Upon completion of hydrolysis, sam-
ples were divided into two equal parts for 8-oxo-dG and oxa-
zolone analyses. DNA hydrolysates from in vitro experiments
were analyzed directly after ﬁltration through Microcon YM-
30 centrifugal ﬁlters (Millipore Corporation, Bedford, MA) to
remove proteins. The ﬁlters were pre-rinsed with water (6 ·
500 ml) to remove glycerol. Analyses of 8-oxo-dG in rat
liver DNA were performed directly without further puriﬁca-
tion. Quantiﬁcation of oxazolone in the rat liver DNA was
carried out following ofﬂine HPLC puriﬁcation as described
below.
Offline HPLC purification of oxazolone from enzymatic
digests of rat liver DNA
Sample volume was adjusted to 500 ml with Milli-Q water,
and the samples were loaded onto an Agilent XDB-C8 col-
umn (4.6 · 100 mm, 5 mm) eluted with the solvent system
of 15 mM ammonium acetate (A) and acetonitrile (B) at a
ﬂow rate of 1 ml/min. The solvent composition was held at
0% B for 2.5 min, and then changed linearly to 4.5% B at
21.5 min and further to 30% B at 24.5 min. Fractions contain-
ing oxazolone and [
15N4]-oxazolone (1.55–3 min) were col-
lected, dried under vacuum and redissolved in 500 mlo f
acetontrile/methanol (3:1) for the second puriﬁcation by
normal phase HPLC. Samples were loaded onto a Waters
(Milford, MA) Atlantis Hilic silica column (2.1 · 150 mm,
5 mm) and eluted with a gradient of acetonitrile (solvent A)
in nanopure water (solvent B) (0 min, 10% B; 18 min, 28%
B; 19 min, 10% B) at a ﬂow rate of 0.3 ml/min. Under these
conditions, oxazolone standard eluted at 15.1 min. To insure
complete collection of oxazolone and its
15N-internal stan-
dard, HPLC fractions were collected from 14 to 16.9 min.
HPLC fractions were dried under vacuum and redissolved
in 20 ml of nanopure water for HPLC-ESI-MS/MS analysis.
Figure 2. ESI
+ MS/MS spectra of oxazolone (a) and [
15N4]-oxazolone (b) obtained at a low collision energy and at a higher collision energy (insert).
Nucleic Acids Research, 2006, Vol. 34, No. 19 5453Blank injections were performed periodically to check for
any cross-contamination.
Capillary HPLC-ESI-MS/MS
Oxazolone analysis was performed with a Thermo-Finnigan
TSQ Quantum Ultra mass spectrometer interfaced with an
Agilent 1100 capillary HPLC. A Thermo Hypersil-Keystone
(Bellefonte, PA) Hypercarb column (0.5 · 100 mm, 5 mm)
was eluted with a gradient of isopropanol/acetonitrile (3:1)
(solvent B) in 0.05% acetic acid (solvent A) (0 min, 0% B;
1 min, 0% B; 8.5 min, 10.7% B; 9.3 min, 0% B; 20 min,
0% B) at a ﬂow rate of 12 ml/min. The mass spectrometer
was operated in the ESI
+ MS/MS mode. The spray voltage
was set to 3.1 kV, the source temperature was 250 C, and
the sheath gas pressure was 30 psi. Product ions of m/z
247.1 ([M + H]
+ of oxazolone nucleoside) and m/z 251.1
(
15N4-oxazolone, internal standard) were obtained, with a col-
lision energy of 14 and a collision gas pressure of 1 mtorr.
The peak width for Q1 and Q3 were both set to 0.70 amu.
Quantitative analyses were performed in selected reaction
monitoring mode using the transitions m/z 247.1!87.1
[M + 2H   dR   CO2]
+ and m/z 251.1!91.1 for oxazolone
and
15N4-oxazolone, respectively. The method was validated by
spiking calf thymus DNA (0.2 mg) with 2 pmol each oxazolone
and
15N4-oxazolone, followed by enzymatic hydrolysis,
HPLC cleanup and HPLC-ESI
+-MS/MS analysis as described
above (Scheme 2). Spiked samples were quantiﬁed to contain
96.7 ± 1.3% of the target oxazolone amount (n ¼ 5). The
same experiment performed in the absence of DNA (pure
standards) yielded an accuracy of 100–103%, with a precision
of 2.62% (N ¼ 8, during several days). The lower limit of
detection for oxazolone standard was estimated as 5 fmol
on column (S/N ¼ 4).
Quantiﬁcation of 8-oxo-dG was achieved with an Agilent
1100 capillary HPLC-ion trap MS. An Agilent Zorbax SB
C18 column (0.5 · 150 mm, 5 mm) was maintained at 10 C.
The column was eluted with a gradient of methanol (solvent
B) in 15 mM ammonium acetate (solvent A) (0 min, 3% B;
18 min, 11% B; 30 min, 70% B) at a ﬂow rate of 12 ml/min.
The mass spectrometer was operated in the ESI
+ MS/MS
mode. The skimmer and capillary exit voltages were main-
tained at 26.8 and 96.9 V, respectively. The accumulation
time was 300 ms. Product ions of m/z 284.1 (8-oxo-dG) and
289.1 (
15N5-8-oxo-dG, internal standard) were obtained with
a fragmentation amplitude of 0.79. Quantitative analyses
were performed in selected reaction monitoring mode using
the transitions m/z 284.1!168.0 [M + 2H   dR]
+ for 8-oxo-
dG and the corresponding transition m/z 289.1!173 for
15N5-
8-oxo-dG (internal standard). The method was validated
by spiking calf thymus DNA (1 mg) with 8-oxo-dG stan-
dard (10 pmol), followed by enzymatic hydrolysis and
HPLC-ESI-MS/MS analysis as described above. Control
material was quantiﬁed to contain 98–111% of the target
amount with a precision of 7.03% (n ¼ 5).
RESULTS
Synthesis and structural characterization of oxazolone
and
15N4-oxazolone
Authentic standards of oxazolone and
15N4-labeled oxazolone
were synthesized by photooxidation of dG or
15N5-dG in the
presence of riboﬂavin. Crude reaction mixtures were sepa-
rated on a reversed phase C8 HPLC column (Agilent Eclipse
XDB-C8) and the identity of each HPLC peak was estab-
lished from the UV and ESI
+ MS spectra (Figures 1 and 2).
Imidazolone (M ¼ 228, MS/MS m/z 229 [M + H]
+!113
[M + 2H   dR]
+) was the major product (50–70% yield) elut-
ing at 4.2 min at our conditions (Figure 1). Minor products
found in the photooxidation mixtures were (2S)-2,50-anhydro-
1-(20-deoxy-b-D-erythro-pentofuranosyl)-5-guanidinylidene-
2-hydroxy-4-oxoimidazolidine (M ¼ 255, MS/MS m/z 256
[M + H]
+!140 [M + 2H - dR]
+ (51) eluting at 3.2 min and
the a-furanose anomer of imidazolone (40) eluting at 5.1 min
(Figure 1a).
Figure 3. Calibration curves for isotope dilution capillary HPLC-ESI
+
MS/MS analysis of oxazolone (a) and 8-oxo-dG (b). Internal standard
amounts were 1 pmol for [
15N5]-8-oxo-dG and 2 pmol for [
15N4]-oxazolone.
Scheme 2. Experimental scheme for HPLC-ESI-MS/MS analysis of
8-oxo-dG and oxazolone in DNA.
5454 Nucleic Acids Research, 2006, Vol. 34, No. 19Isolation of oxazolone nucleoside by HPLC was compli-
cated by its early elution from the reversed phase HPLC col-
umn (tR ¼ 1.9 min, Figure 1a). The majority of previous
studies have employed acetylated nucleosides to facilitate
HPLC separation of the polar dG oxidation products (19).
Since acetyl groups would interfere with our ability to use
the synthetic compound as a standard for quantiﬁcation of
oxazolone in DNA hydrolysates, an alternative approach
using non-acetylated nucleosides was required. Our puriﬁca-
tion procedure of free oxazolone nucleoside included two
HPLC steps. HPLC fractions corresponding to imidazolone
nucleoside (tR ¼ 4.2 min, Figure 1a) were collected and
kept at room temperature overnight to achieve hydrolytic
conversion of imidazolone to oxazolone (Scheme 1). Further
puriﬁcation of oxazolone was accomplished with the use of a
highly hydrophobic Hypercarb column (Thermo Hypersil-
Keystone) (32), which allowed retention of the oxidized
nucleoside (tR ¼ 6.4 min, Figure 1b). The purity of oxazolone
standard was conﬁrmed by UV spectrophotometry (Figure 1b,
inset), mass spectrometry (Figure 2) and proton NMR
(500 MHz
1H NMR data in
6DMSO: (d) 8.05 d 1H
J ¼ 9.3, 4-NH; (d) s 4H, NH2;( d) 5.6 m 1H, J1
0
-2
0 ¼ 7.5,
J1
0
-2
0 ¼ 6.2, H-10;( d) 5.0 d 1H, J ¼ 4.05, CHOH-30;( d)
4.7 d 1H, J ¼ 5.6, CHOH-50;( d) 4.1 m 1H, H-30;( d) 3.6
m 1H, J30–40 ¼ 2.5, J40–500 ¼ 5.0, H-40;( d) 3.4 m 1H, H-50;
(d) 3.3 m 1H, H-500;( d) 2.1 dd 1H, H-20;( d) 2.0 dd 1H, H-
200) and mass spectrometry (Figure 2a). Concentrations of
oxazolone in stock solutions were determined by UV spec-
trophotometry (e233 ¼ 1.833 mM
 1 cm
 1).
15N-labeled oxa-
zolone for use as HPLC-ESI-MS/MS internal standard was
prepared by the same procedure starting with
15N5-dG
(Figure 2b).
Quantitative HPLC-ESI
+-MS/MS method development
for assays of oxazolone and 8-oxo-dG
We employed HPLC-ESI
+-MS/MS because this methodology
does not require chemical derivatization of oxidized nucleo-
sides and affords adequate sensitivity for analyses of DNA
adducts from in vivo sources. Our typical detection limits
for covalently modiﬁed DNA nucleosides are 5–20 fmol
per 100 mg of DNA.
Our experimental procedures for quantitative analysis of
8-oxo-dG and oxazolone in DNA hydrolysates are outlined
in Scheme 2. Early in the analysis, DNA samples were spiked
with a mixture of
15N4 -oxazolone and
5N5-8-oxo-dG which
served as internal standards for capillary HPLC-MS/MS.
DNA was enzymatically digested in the presence of PDE I,
PDE II and DNase at pH 7.0. Our control experiments
(data not shown) conﬁrmed that under these conditions, imi-
dazolone was completely converted to oxazolone, but no fur-
ther degradation of oxazolone nucleoside occurred. No
attempt was made to develop quantitative assay for imida-
zolone because of its inherent instability at physiological con-
ditions. Aliquots of enzymatic digests were analyzed by
HPLC-UV to ensure the completeness DNA hydrolysis and
to rule out any RNA contamination. Following ultraﬁltration
through Centricon YM-30 microﬁlters, samples were injected
onto a capillary HPLC column for HPLC-ESI-MS/MS anal-
ysis (Scheme 2). 8-Oxo-dG was directly analyzed in crude
DNA digests without any pre-puriﬁcation or derivatization
steps to minimize artifactual formation of 8-oxo-dG. To mini-
mize DNA oxidation during enzymatic digestion, TEMPO
(5 mM) was added to all buffers and all solutions were purged
with argon. Samples were kept on ice and either analyzed on
the same day or stored under Ar at  70 C for less than a
week.
The MS/MS fragmentation pattern of oxazolone nucleoside
(m/z ([M+H]
+) ¼ 247.1) at low collision energies is character-
ized by two predominant fragmentation pathways (Figure 2a).
The loss of a molecule of carbon dioxide leads to the major
fragments at m/z 203.1. Unlike typical MS/MS spectra of
native DNA nucleosides (52), product ions corresponding to
the loss of deoxyribose (BH2
+, m/z 131) are less abundant than
the [M+H-CO2]
+ fragments (Figure 2a). This distinct frag-
mentation pattern reﬂects the loss of aromaticity upon oxida-
tion of dG to oxazolone, accompanied by the incorporation
of relatively labile lactone group in the molecule (Scheme 1).
At high collision energies, one major fragment at m/z 87.1
predominated [M + 2H   dR   CO2]
+ .
Mass spectral analysis of
15N-labeled oxazolone standard
(Figure 2b) conﬁrmed the presence of four
15N atoms in the
molecule (M ¼ 250.1 versus 246.1 for unlabeled oxazolone).
Although the starting material (
15N5-dG) contains ﬁve
15N
atoms, one of the nitrogens (the former N-7) was lost as
HCONH2 during oxazolone formation from dG (19). The
observed (+4) mass shift for the mass fragments originating
from
15N4-oxazolone (Figure 2b) is consistent with the
presence of four
15N atoms in the molecule and the reten-
tion of these atoms in [M + H   dR]
+ (m/z 235) and [M +
H   CO2]
+ (m/z 207) ions. As was the case with unlabeled
nucleoside, the major fragmentation process observed at
high collision energies was the loss of deoxyribose and a
molecule of carbon dioxide [M + 2H   dR   CO2]
+ (m/z
91.1).
Our HPLC-ESI-MS/MS method for analysis of oxazolone
is based on selected reaction monitoring of the transition m/z
247.1 [M + H]
+!87.1 [M + 2H   dR   CO2]
+ for
15N0-oxa-
zolone and the corresponding transition m/z 251.1!91.1 for
the
15N4-labeled internal standard. A capillary Hypercarb
HPLC column (0.5 mm i.d.) is eluted at a ﬂow rate of 12
ml/min with a gradient of isopropanol/acetonitrile (3:1) in
0.05% acetic acid. Our HPLC-ESI-MS/MS detection limit
for oxazolone using the TSQ system was estimated as
10 fmol (S/N ¼ 3).
Quantitative analyses of oxazolone in DNA from the in
vivo sources required an additional ofﬂine HPLC puriﬁcation
step because of an interfering impurity present in rat liver
DNA. Our ofﬂine HPLC puriﬁcation scheme included the
use of two different HPLC columns. DNA hydrolysates
were ﬁrst loaded onto a reversed phase C8 HPLC column
to remove the bulk of normal nucleosides. HPLC fractions
corresponding to the expected elution time for oxazolone
were collected, dried under vacuum and further separated
with a Waters (Milford, MA) Atlantis Hilic silica column
(2.1 · 150 mm, 5 mm) eluted with a gradient of acetonitrile
in water. HPLC-puriﬁed samples were dried and reconstituted
in 20 ml of water and injected onto capillary columns for
HPLC-ESI-MS/MS analysis with a triple quadrupole mass
spectrometer. Method was validated by spiking calf thymus
DNA with known amounts of oxazolone and
15N4-oxazolone.
Method accuracy and precision were determined 96.7 ± 1.3%
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racy of 100.6–103% and a precision of 0.97%. Our optimized
HPLC-ESI-MS/MS method was employed for analyses of
oxazolone in rat liver DNA.
Development of quantitative HPLC-ESI
+-MS/MS
method for assays of 8-oxo-dG
In addition to oxazolone, 8-oxo-dG was quantiﬁed in each
DNA sample. Our HPLC-ESI-MS/MS method for 8-oxo-dG
employed selected reaction monitoring of the transitions
284.2 [M + H]
+!168.2 [M + 2H   dR]
+ (8-oxo-dG) and
289.2 [M + H]
+!173.2 [M + 2H   dR]
+ (
15N5 –8-oxo-dG)
on an Agilent 1100 capillary HPLC- Ion Trap MS system.
HPLC separation was performed with a capillary Zorbax
SB-C18 column. The use of a reduced temperature (10 C)
was required to achieve complete separation of 8-oxo-dG
from normal DNA nucleosides. Previous investigators have
noted the ability of dG to oxidize to 8-oxo-dG in the ion
source of the mass spectrometer, potentially interfering with
quantitative analyses (22,53). Our attempts to remove dG by
solid phase extraction on C18 cartridges proved unsuccessful.
Therefore, efﬁcient HPLC separation of 8-oxo-dG from dG
during HPLC-ESI-MS/MS analyses was necessary. A series
of pilot experiments using enzymatic digests of calf thymus
DNA spiked with authentic 8-oxo-dG were performed to
ensure efﬁcient HPLC separation and accurate quantiﬁcation
of 8-oxo-dG in the presence of a large excess of dG and other
native DNA nucleosides. The use of a Zorbax SB-C18 col-
umn with a gradient of acetonitrile in ammonium acetate at
10 C has afforded the necessary separation without the loss
of HPLC resolution (Supplementary Data). 8-Oxo-dG detec-
tion limit on the ion trap system was calculated as 30 fmol (S/
N ¼ 3).
Tests for artifactual oxazolone formation from dG and
8-oxo-dG
In order to evaluate potential artifactual formation of oxa-
zolone from dG during sample processing, rat liver DNA
(250 mg, in duplicate) was spiked with synthetic DNA
oligodeoxynucleotide containing [
14N4]-dG (5 nmol), and
the samples were processed and analyzed as described
above.
15N3-oxazolone formation was analyzed by monitor-
ing the MS/MS transition m/z 250.1 [M + H]
+!90.1 [M +
2H   dR   CO2]
+. Under our conditions, no artifactual oxa-
zolone was detected.
To test for possible formation of oxazolone from 8-oxo-dG
during sample processing, 8-oxo-dG standard (100 nmol) was
dissolved in 250 ml of the digestion buffer containing nucle-
ase enzymes and incubated at 37 C for 18 h to imitate enzym-
atic digestion conditions. Following incubation, the sample
was spiked with
15N3 oxazolone (5 pmol) and subjected to
the same HPLC cleanup as that for DNA from the in vivo
sources (see above). Oxazolone formation was analyzed by
monitoring the MS/MS transition m/z 247.1 [M +
H]
+!88.1 [M + 2H   dR   CO2]
+. The amount of oxazolone
produced from 100 nmol of 8-oxo-dG was 19.7 pmol
( 0.02% conversion). Based on the amounts of 8-oxo-dG
present in rat liver samples (1.1 pmol in 0.1 mg DNA), arti-
factual formation of oxazolone from 8-oxo-dG is negligible
under the conditions of our experiments.
HPLC-ESI
+-MS/MS quantification of 8-oxo-dG and
oxazolone in photooxidized DNA
The newly developed HPLC-ESI-MS/MS methods were
tested by analyzing 8-oxo-dG and oxazolone in calf thymus
DNA subjected to photooxidation in the presence of
riboﬂavin. Riboﬂavin is an endogenous cellular photosensi-
tizer that acts via the Type I mechanism, directly transferring
a single electron from guanine molecule to the excited mole-
cule of the dye (37). This initiates a series of reactions, ulti-
mately leading to 8-oxo-dG and oxazolone (36,39). Under
our experimental conditions (0 C, constant purging with
air), amounts of oxazolone in DNA increased linearly with
the duration of exposure to visible light (5–60 min irradiation,
Figure 4). At short incubation times (0–20 min), 8-oxo-dG
levels were comparable to those of oxazolone. When pho-
tooxidation time was extended to 30–60 min, oxazolone
amounts continued to increase, suggesting that it was refrac-
tory to further oxidation in the presence of Type I photo-
oxidizing agents (Figure 4). In contrast, 8-oxo-dG amounts
reached a plateau following 20 min reaction, probably as a
result of its oxidation to secondary products. Taken together
with validation experiments described above, these in vitro
studies conﬁrmed that our HPLC-ESI-MS/MS methodology
could be used for accurate and reliable quantiﬁcation of
both oxidative lesions in DNA hydrolysates from rat tissues.
HPLC-ESI
+-MS/MS analysis of oxazolone
and 8-oxo-dG in rat liver DNA
The formation of 8-oxo-dG and oxazolone in DNA isolated
from livers of control and diabetic rats maintained on a
high fat, beef tallow-based diet was examined. A previous
study (45) revealed that diabetic rats excreted increased
amounts of lipophilic aldehydes and related carbonyl com-
pounds in their urine as an indication of elevated lipid peroxi-
dation. Representative HPLC-ESI-MS/MS traces for analyses
of 8-oxo-dG and oxazolone in rat liver samples are shown in
Figures 5 and 6, respectively. Oxazolone amounts in rat liver
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Figure 4. Formation of 8-oxo-dG and oxazolone in calf thymus DNA
subjected to photooxidation in the presence of riboflavin. Aliquots of 50 ml
were withdrawn at 0, 5, 10, 15, 20, 30 and 60 min, and analyzed as shown in
Scheme 2.
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7 normal guanines) were approxi-
mately an order of magnitude lower than those of 8-oxo-dG
in the same tissue (3–8 adducts per 10
6 G) (Table 1). The lev-
els of 8-oxo-dG detected in our study were similar to those
determined by a similar method in the livers of control
Sprague–Dawley rats (54). Streptozotocin-induced diabetic
rats contained slightly higher levels of 8-oxo-dG than control
animals (P ¼ 0.009, Table 1), which was consistent with
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Figure 5. HPLC-ESI
+-MS/MS analysis of oxazolone in enzymatic hydrolysates of rat liver DNA (300 mg) following off-line HPLC purification (Scheme 2). An
Agilent 1100 series capillary HPLC was interfaced to a Thermo-Finnigan TSQ Quantum Ultra mass spectrometer. A Thermo Hypersil-Keystone Hypercarb
column (0.5 · 100 mm, 5 mm) was eluted at a flow rate of 12 ml/min with a gradient of isopropanol/acetonitrile (3:1) (solvent B) in 0.05% acetic acid (solvent A).
The spray voltage was set to 3.1 kV, the source temperature was 250 C, and the sheath gas pressure was 30 psi. Quantitative analyses were performed in selected
reaction monitoring mode using the transitions m/z 247.1!87.1 [M + 2H   dR   CO2]
+, and m/z 251.1!91.1 for oxazolone and
15N4-oxazolone, respectively.
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Figure 6. HPLC-ESI
+-MS/MS analysis of 8-oxo-dG in an enzymatic hydrolysate of rat liver DNA (80 mg). An Agilent 1100 series capillary HPLC-ion trap MS
system was used. A Zorbax SB C18 column (0.5 · 150 mm, 5 (m) was maintained at 10 C and eluted at a flow rate of 12 (l/min with a gradient of methanol
(solvent B) in 15 mM ammonium acetate (solvent A). The mass spectrometer was operated in the positive ion MS/MS mode. Quantitative analyses were
performed in selected reaction monitoring mode using the transitions m/z 284.1!168.0 (M + 2H   dR)
+ for 8-oxo-dG and the corresponding transition m/z
289.1!173 for [
15N5]-8-oxo-dG.
Nucleic Acids Research, 2006, Vol. 34, No. 19 5457earlier reports of diabetes-induced increase in urinary
8-hydroxy-20-deoxyguanosine (55). However, no signiﬁcant
differences were observed between oxazolone levels in liver
DNA extracted from the two groups of animals (P ¼ 0.5,
Table 1).
DISCUSSION
Oxidative degradation of DNA appears to be causally
involved in cancer and other human diseases (1–4,6,7,21).
Guanine nucleobases are frequently targeted by oxidants
due to their lowest redox potential among the DNA bases
(6,9). Among guanine oxidation products, 8-oxo-7,8-dihydro-
20-deoxyguanosine (8-oxo-dG) is used widely as a biomarker
of guanine oxidation because of its in vivo incidence and its
facile measurement by HPLC with electrochemical detection
(48). In contrast, another abundant oxidation product of gua-
nine in DNA, oxazolone (Scheme 1), has received relatively
little attention. Oxazolone was ﬁrst discovered by Cadet et al.
(19) as the major product of dG oxidation in the presence of
hydroxyl radicals and photosensitizers. Kino and Saito (10)
have demonstrated that the imidazolone precursor of oxa-
zolone is also formed upon photooxidation of G-containing
single-stranded synthetic oligodeoxynucleotides and pro-
posed that the formation of these lesions, rather than 8-oxo-
dG, is responsible for piperidine-sensitive alkali-labile sites
in DNA subjected to photooxidation (10). Potent mispairing
abilities of oxazolone have been demonstrated in site-speciﬁc
mutagenesis experiments, where it led to  10-fold more G to
T transversions than 8-oxo-dG (31). Taken together, these
results suggest that, if formed in vivo, oxazolone may play
a role in mutagenesis by ROS.
The goal of the present study was to examine the occurrence
of oxazolone in cellular DNA using highly sensitive and
speciﬁc mass spectrometry-based methods. The analytical
methodology developed in the present work allows a direct
and accurate analysis of oxazolone in DNA samples from
biological sources using stable isotope labeling - capillary
HPLC-ESI
+-MS/MS. Our HPLC-ESI-MS/MS limit of detec-
tion for oxazolone was estimated as 5 fmol, with an accuracy
of 96.7 (n ¼ 5) and a precision of 1.3% (n ¼ 5). While this
manuscript was in preparation, Yu et al. (38) reported the
development of a similar HPLC-ESI-MS/MS assay for
oxazolone and its application to quantitative analysis of this
lesion in DNA subjected to peroxynitrite treatment. However,
to our knowledge, no previous reports of the in vivo formation
of oxazolone are available in the literature.
Our results for dose-dependent formation of oxazolone and
8-oxo-dG in photooxidized calf thymus DNA are consistent
with the earlier report of Kino and Sagiyama (56). These
researchers employed HPLC with UV detection to monitor
the formation of imidazolone and 8-oxo-dG in synthetic
DNA duplexes irradiated in the presence of riboﬂavin. As
in our study (Figure 4), the highest yields of 8-oxo-dG
were observed at relatively short irradiation times, followed
by a slow decline at prolonged irradiation (56). In contrast,
Douki and Cadet (37) observed a linear increase in the
amounts of both oxazolone and 8-oxo-dG in photooxidized
DNA with increased irradiation time. This apparent discrep-
ancy can be explained by differences in irradiation times used
in these studies. Indeed, Douki and Cadet (37) stopped pho-
tooxidation at 20 min, i.e. before any non-linear behavior has
been observed in our experiment (Figure 4).
To our knowledge, this report provides the ﬁrst account of
the formation of oxazolone in vivo (Figure 6 and Table 1).
Although its levels were  10-fold lower than those reported
for 8-oxo-dG in this and other studies (54), oxazolone may
be relevant for mutagenesis by ROS because of its mispairing
potency (31) and its resistance to further oxidation (Figure 4).
The reason for the lack of a signiﬁcant difference between
oxazolone amounts detected in liver DNA of diabetic and
control rats examined in this study (Table 1) is as yet unclear.
Future experiments with other animal models of oxidative
stress will employ quantitative HPLC-ESI-MS/MS methods
developed in the present work to help establish whether
oxazolone can serve as a biomarker of DNA oxidation in vivo.
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Supplementary Data are available at NAR Online.
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